← Leaderboards
Jeremy R Wang
Univ Of North Carolina Chapel Hill
$1,462,885
Attributed
$2,380,627
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $627.9K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,380,627 · 3
By mechanism
R01$1,226,342 · 1
K01$754,455 · 1
R21$399,830 · 1
Top collaborators
- Thomas Blick Alexander4 shared
- Javeria Aijaz1 shared
Most similar at Univ Of North Carolina Chapel Hill
Same institution · by research overlap
- Janelle C Arthur$3,483,239
- Thomas Blick Alexander$708,430
- Samuel Lai$12,082,303
- Yuri Fedoriw$2,581,863
- Tessa Andermann$1,013,095
Others in their field
Other Emerging Leaders on “Sampling”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$181,167,581
- Beth Baseler · Leidos Biomedical Research, Inc.$105,136,677
- Scott Topper · Broad Institute, Inc.$77,958,806
- Paul F Gallagher · Woods Hole Oceanographic Institution$63,916,876
- Leonard Freedman · Leidos Biomedical Research, Inc.$60,323,945
- Dale Sandler · Social And Scientific Systems, Inc.$59,740,435
Research focus
SamplingClassificationProtocols DocumentationTechnologyGenomicsCostNanoporeSiteBiologicalModernizationSequencing PlatformComputing MethodologiesClinically SignificantDeep SequencingBaseBacterial CommunityCrohn&AposDistalBacteriaComplex16s Ribosomal Rna SequencingBiopsyBiopsy SpecimenCecum
Grant awards (9)
Characterization of Diverse Pediatric Cancers in LMIC Using Low-Cost Nanopore Sequencing$598,403
R01 · FY2025 · CA · contact PI
Characterization of Diverse Pediatric Cancers in LMIC Using Low-Cost Nanopore Sequencing$627,939
R01 · FY2024 · CA · contact PI
Novel Sequencing Based Diagnostics for Leukemia in Low Resource Settings$181,741
R21 · FY2023 · CA
Advanced sequencing as a novel diagnostic tool to discover strain-level variation and function of mucosal-adherent bacteria contributing to IBD$150,591
K01 · FY2023 · DK · contact PI
Novel Sequencing Based Diagnostics for Leukemia in Low Resource Settings$218,089
R21 · FY2022 · CA
Advanced sequencing as a novel diagnostic tool to discover strain-level variation and function of mucosal-adherent bacteria contributing to IBD$150,591
K01 · FY2022 · DK · contact PI
Advanced sequencing as a novel diagnostic tool to discover strain-level variation and function of mucosal-adherent bacteria contributing to IBD$150,591
K01 · FY2021 · DK · contact PI
Advanced sequencing as a novel diagnostic tool to discover strain-level variation and function of mucosal-adherent bacteria contributing to IBD$150,591
K01 · FY2020 · DK · contact PI
Advanced sequencing as a novel diagnostic tool to discover strain-level variation and function of mucosal-adherent bacteria contributing to IBD$152,091
K01 · FY2019 · DK · contact PI